Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
Blue curve MMWR spacer

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: Type 508 Accommodation in the subject line of e-mail.

Notice to Readers: Addition of Novel Influenza A Virus Infections to the National Notifiable Diseases Surveillance System, 2007

On January 9, 2007, the Executive Committee of the Council of State and Territorial Epidemiologists (CSTE) approved an interim position statement, adding novel influenza A virus infections* to the National Notifiable Diseases Surveillance System (NNDSS) (1). This issue of MMWR adds novel influenza A virus infection to Table I (Provisional cases of infrequently reported notifiable diseases, United States). The addition of this infection to NNDSS is expected to facilitate the following: 1) timely identification and confirmation of cases, 2) timely reporting of cases to CDC, and 3) early initiation of appropriate health responses to human infections with novel influenza A viruses that might have pandemic potential.

These infections must be reported immediately to the World Health Organization under the revised International Health Regulations (IHR) approved by the World Health Assembly on May 23, 2005 (2). The revised regulations will take effect in the United States on June 15, 2007. CDC is collaborating with partners to develop plans to implement the revised IHR by that date.


  1. Council of State and Territorial Epidemiologists. National reporting of novel influenza A virus infections, submitted January 5, 2007, and approved January 9, 2007. Available at
  2. World Health Organization. Revision of the international health regulations. Geneva, Switzerland: World Health Organization; 2005. Available at

* Defined as human infections with influenza A viruses that are different from currently circulating human influenza H1 and H3 viruses.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to

Date last reviewed: 4/5/2007


Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A


Department of Health
and Human Services